SNY
Genzyme India Private Limited is a biotechnology company focused on uncovering and providing transformative therapies for patients suffering from rare and unmet medical needs. Established in 1981 and now a part of Sanofi, Genzyme specializes in treatments for lysosomal storage disorders and has broadened its scope to address conditions like thyroid cancer and multiple sclerosis. With a commitment to patient communities, Genzyme emphasizes collaboration to tailor its research and therapy development, thereby enhancing the quality of care for those it serves.
No recent deals for this company.